{"id":"98418688-828b-553f-9b80-7e252699138a","stable_key":"649e861b-265a-5912-bc36-3a73e53ef892:l-serine-naxd-small-molecule-rescue","predicate":"partially_restores","statement":"Nicotinamide riboside and inosine partly improved viability of galactose-grown NAXD-null HAP1 cells, with metabolomics suggesting different mechanisms involving serine synthesis.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"e444205d-9717-54e3-9ef4-024053f97797","mechanism_event_label":"Two metabolic inputs partly bypassed a specific cellular vulnerability.","subject":{"id":"7bb72d0e-e20d-51bc-b88b-7ff29dc2ad4a","slug":"nicotinamide-riboside","display_name":"Nicotinamide riboside","entity_type_key":"small_molecule"},"object":{"id":"26fd8f4b-bd3a-5826-8192-b05faf88e571","slug":"human-naxd-null-growth","display_name":"Growth of human NAXD-null HAP1 cells under galactose stress","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"e444205d-9717-54e3-9ef4-024053f97797","stable_key":"649e861b-265a-5912-bc36-3a73e53ef892:l-serine-naxd-small-molecule-rescue-event","event_type":"observed_relationship","label":"Two metabolic inputs partly bypassed a specific cellular vulnerability.","description":"Nicotinamide riboside and inosine partly improved viability of galactose-grown NAXD-null HAP1 cells, with metabolomics suggesting different mechanisms involving serine synthesis.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"7bb72d0e-e20d-51bc-b88b-7ff29dc2ad4a","slug":"nicotinamide-riboside","display_name":"Nicotinamide riboside","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"26fd8f4b-bd3a-5826-8192-b05faf88e571","slug":"human-naxd-null-growth","display_name":"Growth of human NAXD-null HAP1 cells under galactose stress","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"c882cd0b-9d83-5b07-bd1c-fe4d45657dcb","slug":"l-serine","display_name":"L-Serine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"67e4baa2-eb17-5b9f-9104-1902189956f7","slug":"naxd","display_name":"Human NAD(P)HX dehydratase / NAXD","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"270cbce0-c607-5f42-94b3-e9154bc67e91","slug":"inosine","display_name":"Inosine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary full text","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human cell add-back experiments.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Cell rescue is not established treatment for inherited NAXD disease.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"l-serine","display_name":"L-Serine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Two metabolic inputs partly bypassed a specific cellular vulnerability.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Failure to repair damaged NAD(P)H blocks de novo serine synthesis in human cells. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39789421/ · DOI 10.1186/s11658-024-00681-8","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"2bd6c030-d2bc-5709-ad87-e13167e0a990","evidence_kind":"source_excerpt","locator":"Lines 134-140","start_line":134,"end_line":140,"excerpt":"## l-serine-naxd-small-molecule-rescue\nTwo metabolic inputs partly bypassed a specific cellular vulnerability.\nNicotinamide riboside and inosine partly improved viability of galactose-grown NAXD-null HAP1 cells, with metabolomics suggesting different mechanisms involving serine synthesis.\nModel: Human cell add-back experiments.\nLimitations: Cell rescue is not established treatment for inherited NAXD disease.\nEvidence access: Primary full text\nFailure to repair damaged NAD(P)H blocks de novo serine synthesis in human cells. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39789421/ · DOI 10.1186/s11658-024-00681-8","model_system":"Human cell add-back experiments.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"70bcf57a-36bb-563f-9073-2d616e5f155a","stable_key":"import-649e861b-265a-5912-bc36-3a73e53ef892","title":"L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"22a750ce2b94f8607268c58322c48c4f0468f403b72a4008307538a6e5ff86d5","revision_id":"c1d6a7e1-9558-5bc6-9e3b-7080c26d3dbc","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}